Adjuvant nivolumab for stage III/IV melanoma: Evaluation of safety outcomes and association with recurrence-free survival

Mario Mandala, James Larkin, Paolo Antonio Ascierto, Michele Del Vecchio, Helen Gogas, C. Lance Cowey, Ana Arance, Stéphane Dalle, Michael Schenker, Jean Jacques Grob, Vanna Chiarion-Sileni, Ivan Marquez, Marcus O. Butler, Anna Maria Di Giacomo, Jose Lutzky, Luis De La Cruz-Merino, Victoria Atkinson, Petr Arenberger, Andrew Hill, Leslie FecherMichael Millward, Nikhil I. Khushalani, Veerle De Pril, Maurice Lobo, Jeffrey Weber

Research output: Contribution to journalArticlepeer-review

11 Citations (Web of Science)

Fingerprint

Dive into the research topics of 'Adjuvant nivolumab for stage III/IV melanoma: Evaluation of safety outcomes and association with recurrence-free survival'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology